Patent Assignment
Reel/Frame 038292/0131
Assignment of Assignor's Interest
Recorded: 2016-04-15
Pages: 10
Assignor
MERRION RESEARCH III LIMITED
Executed: 2016-03-22
Assignee
NOVO NORDISK A/S
NOVO ALLÉ, BAGSVAERD, 2880, DENMARK
Covered Properties
(27)
Peptides Which Enhance Transport Across Tissues and Methods of Identifying and Using the Same
Patent:
6,117,632 →
Application:
08/746,411 →
Composition and Method for Enhancing Paracellular Transport Across Cell Layers
Patent:
6,346,613 →
Application:
09/160,496 →
Composition and Method for Enhancing Transport Across Gastrointestinal Tract Cell Layers
Patent:
6,423,334 →
Application:
09/163,510 →
Method for Inducing a Cell-Mediated Immune Response and Improved Parenteral Vaccine Formulations Thereof
Patent:
7,087,236 →
Application:
09/386,266 →
Solid Oral Dosage Form Containing an Enhancer
Membrane Translocating Peptide Drug Delivery System
Patent:
6,780,846 →
Application:
09/671,089 →
Permeation Enhancers
Peyer's Patch and/or M-Cell Targeting Ligands
Delivery of a Bioactive Material
Peyer's Patch and/or M-Cell Targeting Ligands
Solid Oral Dosage Form Containing an Enhancer
Solid Oral Dosage Form Containing an Enhancer
Solid Oral Dosage Form Containing an Enhancer
Compositions of peptides and processes of preparation thereof
Application:
12/436,990 →
Publication:
US 2009/0280169
Compositions of Gnrh Related Compounds and Processes of Preparation
Solid Oral Dosage Form Containing An Enhancer
Solid Oral Dosage Form Containing an Enhancer
Delivery of a Bioactive Material
Composition and drug delivery of bisphosphonates
Application:
12/712,527 →
Publication:
US 2010/0215743
Solid Oral Dosage Form Containing An Enhancer
Solid Oral Dosage Form Containing an Enhancer
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
Application:
13/014,156 →
Publication:
US 2011/0182985
Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration
Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration
Application:
13/242,601 →
Publication:
US 2012/0156294
Pharmaceutical Compositions of Iron for Oral Administration
Solid Oral Dosage Form Containing an Enhancer
Compositions of GnRH related compounds and processes of preparation
Application:
14/636,756 →
Publication:
US 2015/0238561
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 23, 2004
From: ELAN CORPORATION, PLC
To: ADAPTIV BIOPHARMA LIMITED
Reel/Frame 014763/0764 →
Change of Name
Nov 12, 2004
From: ADAPTIV BIOPHARMA LIMITED
To: MERRION BIOPHARMA LIMITED
Reel/Frame 015980/0444 →
Change of Name
Nov 12, 2004
From: ADAPTIV BIOPHARMA LIMITED
To: MERRION BIOPHARMA LIMITED
Reel/Frame 015983/0983 →
Change of Name
Nov 15, 2004
From: ADAPTIV BIOPHARMA LIMITED
To: MERRION BIOPHARMA LIMITED
Reel/Frame 015979/0794 →
Assignment of Assignor's Interest
Nov 15, 2004
From: ELAN CORPORATION, PLC
To: ADAPTIV BIOPHARMA LIMITED
Reel/Frame 015982/0349 →
Assignment of Assignor's Interest
Nov 15, 2004
From: ELAN CORPORATION, PLC
To: ADAPTIV BIOPHARMA LIMITED
Reel/Frame 015982/0337 →
Assignment of Assignor's Interest
Nov 15, 2004
From: ELAN CORPORATION, PLC
To: ADAPTIV BIOPHARMA LIMITED
Reel/Frame 015982/0307 →
Assignment of Assignor's Interest
Nov 15, 2004
From: ELAN CORPORATION, PLC
To: ADAPTIV BIOPHARMA LIMITED
Reel/Frame 015980/0532 →
Change of Name
Nov 15, 2004
From: ADAPTIV BIOPHARMA LIMITED
To: MERRION BIOPHARMA LIMITED
Reel/Frame 015979/0808 →
Change of Name
Nov 15, 2004
From: ADAPTIV BIOPHARMA LIMITED
To: MERRION BIOPHARMA LIMITED
Reel/Frame 015979/0800 →
Assignment of Assignor's Interest
Nov 15, 2004
From: ELAN, CORPORATION, PLC
To: ADAPTIV BIOPHARMA LIMITED
Reel/Frame 015979/0518 →
Assignment of Assignor's Interest
Nov 18, 2004
From: MERRION BIOPHARMA LIMITED (FORMERLY KNOWN AS ADAPTIV BIOPHARMA LIMITED)
To: MERRION RESEACH I LIMITED (FORMERLY KNOWN AS ADAPTIV RESEARCH I LIMITED)
Reel/Frame 016004/0165 →
Assignment of Assignor's Interest
Nov 18, 2004
From: MERRION BIOPHARMA LIMITED (FORMERLY KNOWN AS ADAPTIVE BIOPHARMA LIMITED)
To: MERRION RESEARCH I LIMITED (FORMERLY KNOWN AS ADAPTIV RESEARCH I LIMITED)
Reel/Frame 015993/0152 →
Assignment of Assignor's Interest
Nov 18, 2004
From: MERRION BIOPHARMA LIMITED (FORMERLY KNOWN AS ADAPTIV BIOPHARMA LIMITED)
To: MERRION RESEARCH I LIMITED (FORMERLY KNOWN AS ADAPTIV RESEARCH I LIMITED)
Reel/Frame 015993/0164 →
Assignment of Assignor's Interest
Nov 18, 2004
From: MERRION BIOPHARMA LIMITED (FORMERLY KNOWN AS ADAPTIV BIOPHARMA LIMITED)
To: MERRIION RESEARCH I LIMITED
Reel/Frame 015994/0650 →
Assignment of Assignor's Interest
Dec 6, 2004
From: ELAN CORPORATION, PLC
To: ADAPTIV BIOPHARMA LIMITED
Reel/Frame 016043/0684 →
Assignment of Assignor's Interest
Dec 8, 2004
From: MERRION BIOPHARMA LIMITED (FORMERLY KNOWN AS ADAPTIV BIOPHARMA LIMITED)
To: MERRION RESEARCH I LIMITED (FORMERY KNOWN AS ADAPTIV RESEARCH I LIMITED)
Reel/Frame 016061/0289 →
Change of Name
Dec 8, 2004
From: ADAPTIV BIOPHARMA LIMITED
To: MERRION BIOPHARMA LIMITED
Reel/Frame 016046/0109 →
Assignment of Assignor's Interest
May 21, 2007
From: LEONARD, THOMAS W.
To: MERRION RESEARCH II LIMITED
Reel/Frame 019318/0051 →
Assignment of Assignor's Interest
Oct 9, 2007
From: CUMMING, KENNETH I; RAMTOOLA, ZEBUNISSA; LEONARD, THOMAS W
To: MERRION RESEARCH I LIMITED
Reel/Frame 019932/0632 →
Change of Name
Jun 24, 2008
From: MERRION RESEARCH I LIMITED
To: MERRION RESEARCH II LIMITED
Reel/Frame 021141/0871 →
Change of Name
Jun 27, 2008
From: MERRION RESEARCH II LIMITED
To: MERRION RESEARCH III LIMITED
Reel/Frame 021189/0291 →
Assignment of Assignor's Interest
Jun 12, 2009
From: LEONARD, THOMAS W.
To: MERRION RESEARCH III LIMITED
Reel/Frame 022816/0214 →
Assignment of Assignor's Interest
Nov 9, 2009
From: LEE, AMANDA; ADAMCZYK, BOZENA; COUGHLAN, DAVID C.; O'TOOLE, EDEL
To: MERRION RESEARCH III LIMITED
Reel/Frame 023487/0650 →
Assignment of Assignor's Interest
May 6, 2010
From: LEONARD, THOMAS W.
To: MERRION RESEARCH III LIMITED
Reel/Frame 024346/0878 →